Boston Scientific (BSX) Tops Q4 EPS by 7c; Issues Strong Outlook; Expands Restructuring
Tweet Send to a Friend
Boston Scientific Corp. (NYSE: BSX) reported Q4 EPS of $0.18, $0.07 better than the analyst estimate of $0.11. Revenue for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
